D'Arienzo, V.* ; Magri, A.* ; Harris, J.M.* ; Wing, P.A.C.* ; Ko, C. ; Rubio, C.O.* ; Revill, P.A.* ; Protzer, U. ; Balfe, P.* ; McKeating, J.A.*
A PCR assay to quantify patterns of HBV transcription.
J. Gen. Virol. 102:001373 (2019)
Hepatitis B virus (HBV) is the prototype member of the family Hepadnaviridae and replicates via episomal copies of a covalently closed circular DNA (cccDNA) genome of approximately 3.2 kb. The chromatinization of this small viral genome, with overlapping open reading frames and regulatory elements, suggests an important role for epigenetic pathways to regulate HBV transcription. However, the host pathways that regulate HBV transcription and the temporal nature of promoter usage in infected cells are not well understood, in part due to the compact genome structure and overlapping open reading frames. To address this we developed a simple and cost-effective PCR assay to quantify the major viral RNAs and validated this technique using current state-of-art de novo HBV infection model systems. Our PCR method is three orders of magnitude more sensitive than Northern blot and requires relatively small amounts of starting material, making this an attractive tool for assessing HBV transcription.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Hepatitis B Virus ; Rna ; Transcription
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
0022-1317
e-ISSN
1465-2099
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 102,
Issue: 3,
Pages: ,
Article Number: 001373
Supplement: ,
Series
Publisher
Society for General Microbiology
Publishing Place
Charles Darwin House, 12 Roger St, London Wc1n 2ju, Erks, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-502700-003
Grants
Wellcome Trust
MRC
EU 2020 Research and Innovation Programme Consortia HEP-CAR
Copyright
Erfassungsdatum
2020-01-15